An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques
Science Translational Medicine · 15.10.2025 · 17 (820)
DOI: 10.1126/scitranslmed.ady2282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 15.10.2025. Verfasst von Ninaad Lasrado und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Influenza A Virus, H5N1 Subtype, Influenza Vaccines, Orthomyxoviridae Infections, Immunization, Secondary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The H5N1 clade 2.3.4.4b avian influenza virus outbreak in poultry and dairy cattle is a potential pandemic threat for humans. A safe and effective H5N1 influenza vaccine will be needed if the virus acquires the capacity for efficient human-to-human transmission and may also be useful as a veterinary vaccine. In this study, we demonstrate robust vaccine protection in a lethal model of H5N1 clade 2.3.4.4b influenza infection in cynomolgus macaques. We vaccinated 24 cynomolgus macaques with mRNA or rhesus adenovirus serotype 52 (RhAd52) vaccines expressing the hemagglutinin (HA) from H5N1 clade 2.3.4.4b by the intramuscular or intratracheal route and challenged them with the H5N1 human isolate hu-TX37-H5N1. Of sham control animals, 83% (five of six) developed severe rapidly progressive consolidative pneumonia and were euthanized by days 5 to 7 after challenge. In contrast, 100% (17 of 17) of vaccinated macaques survived and controlled virus replication to undetectable titers in both the upper and lower respiratory tracts by days 4 to 14 after challenge. Mucosal boosting with the RhAd52 HA vaccine generated robust mucosal antibody and T cell responses and afforded 6.3 and 5.1 log 10 median viral load reductions in viral RNA with no detectable infectious virus titers compared with sham controls in bronchoalveolar lavage and nasal swabs, respectively. These data demonstrate that an adenovirus-vectored vaccine can protect against lethal H5N1 clade 2.3.4.4b challenge in nonhuman primates and further highlight the importance of vaccine-elicited mucosal immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
- Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA.
- Bioqual Inc., Rockville, MD 20850, USA.
- Ragon Institute of Mass General, MIT, and Harvard, Cambridge MA 02139, USA.
ORCID-Profile: Ninaad Lasrado, Liping Wang, Jinyan Liu, Annika Rössler, Jayeshbhai Chaudhari, Qixin Wang, Jonathon J Stone, Dalia N Cabrera-Barragan, Alejandra Waller-Pulido, Samuel J Nangle, Anthony Cook, Christopher Kitajewski, Laurent Pessaint, Mark G Lewis, Hanne Andersen, Amanda J Martinot, Ryan P McNamara, Dan H Barouch
Förderung
- NIAID NIH HHS
Zitieren
APA
Lasrado, N., Wang, L., Liu, J., Rössler, A., Chaudhari, J., Wang, Q., Stone, J. J., Granados-Contreras, F. A., Wu, J., Cabrera-Barragan, D. N., Waller-Pulido, A., Nangle, S. J., Shah, K., Boduch, R., Warke, S., Cook, A., Kitajewski, C., Pessaint, L., Lewis, M. G., …, & Barouch, D. H. (2025). An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques. Science Translational Medicine, 17(820). https://doi.org/10.1126/scitranslmed.ady2282
Vancouver
Lasrado N, Wang L, Liu J, Rössler A, Chaudhari J, Wang Q, et al. An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques. Science Translational Medicine. 2025;17(820). doi:10.1126/scitranslmed.ady2282
BibTeX
@article{Lasrado2025,
author = {Lasrado, Ninaad and Wang, Liping and Liu, Jinyan and Rössler, Annika and Chaudhari, Jayeshbhai and Wang, Qixin and Stone, Jonathon J and Granados-Contreras, Francisco Armando and Wu, Jessica and Cabrera-Barragan, Dalia N and Waller-Pulido, Alejandra and Nangle, Samuel J and Shah, Krishna and Boduch, Reed and Warke, Siddhesh and Cook, Anthony and Kitajewski, Christopher and Pessaint, Laurent and Lewis, Mark G and Andersen, Hanne and Martinot, Amanda J and McNamara, Ryan P and Barouch, Dan H},
title = {An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {820},
doi = {10.1126/scitranslmed.ady2282}
}
EUVIMED